LENS - Presbia PLC

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.35
-0.09 (-3.69%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.44
Open2.38
Bid2.28 x 2200
Ask3.10 x 1000
Day's Range2.34 - 2.48
52 Week Range1.86 - 7.14
Volume21,990
Avg. Volume26,993
Market Cap40.236M
Beta0.04
PE Ratio (TTM)N/A
EPS (TTM)-1.04
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.50
Trade prices are not sourced from all markets
  • Business Wire3 months ago

    Presbia Announces New Management Appointments

    Presbia PLC  , an ophthalmic device company and leader in near-vision restoration, announced that Casey Lind has been appointed as Chief Operating Officer effective February 12, 2018.

  • Capital Cube5 months ago

    ETFs with exposure to Presbia Plc : January 1, 2018

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to Presbia Plc : December 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Business Wire5 months ago

    Presbia Announces Board and Management Changes and Financing Proposal to Operate Through to the End of 2018

    Presbia PLC  , an ophthalmic device company and leader in near-vision restoration, announces that it has re-ordered its operational priorities to focus its resources on FDA approval as well as ongoing clinical and commercial efforts in Germany and South Korea.

  • Capital Cube6 months ago

    ETFs with exposure to Presbia Plc : November 21, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Should You Be Holding Presbia PLC (LENS) Right Now?
    Simply Wall St.8 months ago

    Should You Be Holding Presbia PLC (LENS) Right Now?

    For Presbia PLC’s (NASDAQ:LENS) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measures LENS’sRead More...

  • Business Wire8 months ago

    Presbia to Participate in Rodman & Renshaw 19th Annual Global Investment Conference

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration that has developed the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced that Todd Cooper, President and CEO, is scheduled to present at the Rodman & Renshaw 19th Annual Investment Conference.

  • Capital Cube10 months ago

    ETFs with exposure to Presbia Plc : August 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Presbia Plc Here are 5 ETFs with the largest exposure to LENS-US. Comparing the performance and risk of Presbia Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Presbia Plc :LENS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
    Capital Cubelast year

    Presbia Plc :LENS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017

    Categories: Yahoo FinanceGet free summary analysis Presbia Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Presbia Plc – Tandem Diabetes Care, Inc., Dextera Surgical, Inc. and Ekso Bionics Holdings, Inc. (TNDM-US, DXTR-US and EKSO-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • Business Wirelast year

    Presbia to Participate in Jefferies 2017 Global Healthcare Conference

    Presbia PLC , an ophthalmic device company and leader in near-vision restoration that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today that Todd Cooper, President and CEO, is scheduled to present at the Jefferies 2017 Global Healthcare Conference on Tuesday, June 6th, at 11:30 a.m.